Bai Q - Search Results

1

Partial omentectomy maybe practicable for T3 or shallower gastric cancer patients.

Lin Q, Bai Q, Huang Q, Huang Y, Gao J, Zhang Y. Lin Q, et al. Among authors: bai q. Cancer Med. 2023 Jan;12(2):1204-1216. doi: 10.1002/cam4.4980. Epub 2022 Jul 20. Cancer Med. 2023. PMID: 35856487 Free PMC article.

2

IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma.

Jiang XN, Yu F, Xue T, Xia QX, Bai QM, Yu BH, Shui RH, Zhou XY, Zhu XZ, Cao JN, Hong XN, Li XQ. Jiang XN, et al. Cancer Med. 2023 May;12(9):10684-10693. doi: 10.1002/cam4.5828. Epub 2023 Apr 20. Cancer Med. 2023. PMID: 37081786 Free PMC article.

3

E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition.

Qi P, Lin WR, Zhang M, Huang D, Ni SJ, Zhu XL, Bai QM, Sheng WQ, Du X, Zhou XY. Qi P, et al. Cancer Manag Res. 2018 Aug 10;10:2563-2571. doi: 10.2147/CMAR.S171652. eCollection 2018. Cancer Manag Res. 2018. PMID: 30127643 Free PMC article.

4

Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients.

Qi P, Yang Y, Bai QM, Xue T, Ren M, Yao QL, Yang WT, Zhou XY. Qi P, et al. Breast Cancer Res Treat. 2021 Apr;186(2):327-342. doi: 10.1007/s10549-020-06075-6. Epub 2021 Jan 13. Breast Cancer Res Treat. 2021. PMID: 33439420 Free PMC article.

5

Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients.

Ji G, Yao Q, Bao L, Zhang J, Bai Q, Zhu X, Tu X, Bi R, Zhou X. Ji G, et al. Among authors: bai q. Ann Transl Med. 2021 Mar;9(6):453. doi: 10.21037/atm-20-6827. Ann Transl Med. 2021. PMID: 33850850 Free PMC article.

6

Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas.

Ji G, Bao L, Yao Q, Zhang J, Zhu X, Bai Q, Shao Z, Yang W, Zhou X. Ji G, et al. Among authors: bai q. J Cancer Res Clin Oncol. 2021 Oct;147(10):2935-2944. doi: 10.1007/s00432-021-03696-2. Epub 2021 Jul 13. J Cancer Res Clin Oncol. 2021. PMID: 34254208

7

A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China.

Zhou S, Lv H, Li A, Li M, Zhong S, Lu H, Zhou X, Bai Q, Yang W. Zhou S, et al. Among authors: bai q. BMC Cancer. 2023 Jan 25;23(1):84. doi: 10.1186/s12885-023-10531-z. BMC Cancer. 2023. PMID: 36698078 Free PMC article.

8

Conversion of ER and HER2 Status After Neoadjuvant Therapy in Chinese Breast Cancer Patients.

Bo J, Yu B, Bi R, Xu X, Cheng Y, Tu X, Bai Q, Yang W, Shui R. Bo J, et al. Among authors: bai q. Clin Breast Cancer. 2023 Jun;23(4):436-446. doi: 10.1016/j.clbc.2023.03.002. Epub 2023 Mar 8. Clin Breast Cancer. 2023. PMID: 36990841

9

Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing.

Bai Q, Lv H, Bao L, Yang Y, Zhang X, Chang H, Xue T, Ren M, Zhu X, Zhou X, Yang W. Bai Q, et al. Breast Cancer (Dove Med Press). 2023 Aug 3;15:563-575. doi: 10.2147/BCTT.S420738. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 37554155 Free PMC article.

10

Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.

Ren M, Cai X, Jia L, Bai Q, Zhu X, Hu X, Wang Q, Luo Z, Zhou X. Ren M, et al. Among authors: bai q. BMC Cancer. 2023 Dec 1;23(1):1175. doi: 10.1186/s12885-023-11563-1. BMC Cancer. 2023. PMID: 38041048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,449 results

Search Page

Filters